Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.
Mosbah H, Vantyghem MC, Nobécourt E, Andreelli F, Archambeaud F, Bismuth E, Briet C, Cartigny M, Chevalier B, Donadille B, Daguenel A, Fichet M, Gautier JF, Janmaat S, Jéru I, Legagneur C, Leguier L, Maitre J, Mongeois E, Poitou C, Renard E, Reznik Y, Spiteri A, Travert F, Vergès B, Zammouri J, Vigouroux C, Vatier C.
Mosbah H, et al. Among authors: nobecourt e.
Diabetes Obes Metab. 2022 Aug;24(8):1565-1577. doi: 10.1111/dom.14726. Epub 2022 May 12.
Diabetes Obes Metab. 2022.
PMID: 35445532
Free PMC article.